Mavefund EN
Pennant Group Inc logo

Pennant Group Inc

PNTG
Letzter Kurs (USD) US$37.08
Marktkapitalisierung (USD) US$1.3b
Kursänderung 12 Monate 52.72%
Loading the 12-month Mave Thesis and 1-month news signal

Start Heute Aktien Watchlist

Pennant Group Inc Überblick

Branche: Healthcare Providers & Services

Sektor: Healthcare

The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors, who are independent or who require some support. The company operates home health, hospice, and senior living communities throughout Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho. The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medi

Research-Überblick

Letztes Berichtsdatum 2026-08-05

Diese Mavefund-Research-Seite bündelt geprüfte Informationen zu Pennant Group Inc (PNTG): Unternehmensprofil, Kursverlauf, verknüpfte Primärquellen, verfügbare Finanzberichte, Research-Signale und zu prüfende Risiken.

Börsennotierung
PNTG · Nasdaq · MIC XNAS
Land
United States
Handelswährung
USD
Branche
Healthcare Providers & Services
Finanzdaten
Jahres- und Zwischenabschlüsse verfügbar
Letzte Primärquelle
SEC EDGAR · veröffentlicht 2026-08-05
Primärquellen

Die Abdeckung wird automatisch aktualisiert und erst nach einer Datenintegritätsprüfung veröffentlicht. Nur Research-Unterstützung; keine persönliche Anlageberatung.

Mavefund ordnet die verfügbaren Fundamentaldaten, Bewertungskennzahlen und Risikofaktoren von Pennant Group Inc für einen nachvollziehbaren Research-Prozess ein.

Score

Veröffentlichte Ergebnisse

Was das Unternehmen berichtet hat – mit kompakter Quellenangabe.

Veröffentlicht Aug 05, 2026

Quarterly result summary

Revenue was $298M (+35.8% YoY); EPS was $0.25 (reported).

Revenue $298M +35.8% YoY
EPS $0.25 reported
Operating income $17.2M +49% YoY
Net income $10.9M +37% YoY

Was sich verändert hat

  • Revenue +35.8% YoY to $298M; EPS reported to $0.25.
  • Operating income +49% YoY to $17.2M.
  • Net income +37% YoY to $10.9M.

Guidance / outlook

we expect to fully complete by the middle of the fourth quarter.

Earnings release Bericht öffnen

Source: SEC EDGAR company-filed earnings materials. Dates and source identifiers are retained for verification; review the original filing before relying on extracted report details.

Weitere aktuelle Ergebnisunterlagen

Geprüfte Signal-Evidenz

Aktuelle Nachrichten

Unternehmensrelevante Artikel aus Quellen, die die Relevanz- und Zuverlässigkeitsprüfung des Mave Signals bestehen.

Keine qualifizierten Unternehmensnachrichten in den letzten 14 Tagen

Kein aktueller Artikel bestand sowohl die Unternehmensrelevanz- als auch die Quellenzuverlässigkeitsprüfung. Das Research nutzt weiterhin die übrigen verfügbaren Berichte, Fundamentaldaten, Marktdaten und Bewertungs-Inputs.

Gewinn je Aktie

Score 4.00/5
Pennant Group Inc boasts a high score, as its Earnings Per Share (EPS) has demonstrated consistent growth over the past six years. Notable counterparts in the sector with high scores includes Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
In Healthcare Providers & Services industry , Apollo Medical Holdings Inc , Privia Health Group Inc , Psychemedics Corporation are companies with high ratings.

Eigenkapitalrendite

Score 4.30/5
Pennant Group Inc stands out with a superior score in the Return on Equity (ROE) section, surpassing the sector median value and showcasing its strong performance in this metric. The top companies in the same sector include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
Pennant Grou... PNTG US$1.3b
Zoetis Inc ZTS US$31.9b
IQVIA Holdin... IQV US$34.8b
Agilent Tech... A US$37.9b

Nettomarge

Score 4.43/5
Pennant Group Inc commands a high score, propelled by its net margin consistently outpacing the sector median value and exhibiting continuous growth in recent six years; noteworthy counterparts in the sector, boasting similarly high scores, include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
Pennant Grou... PNTG US$1.3b
Zoetis Inc ZTS US$31.9b
IQVIA Holdin... IQV US$34.8b
Agilent Tech... A US$37.9b

Aktienrückkäufe

In Healthcare Providers & Services industry , Apollo Medical Holdings Inc , Privia Health Group Inc , Psychemedics Corporation are companies with high ratings.

Verschuldung

Score 1.24/5
Pennant Group Inc registers a lower score in the category as a result of its elevated leverage ratio over the past six years compared to the sector median value. Conversely, other companies in the same sector, including Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc have achieved high scores.
Pennant Grou... PNTG US$1.3b
Zoetis Inc ZTS US$31.9b
IQVIA Holdin... IQV US$34.8b
Agilent Tech... A US$37.9b

Finanzberichte

Vom Unternehmen veröffentlichte Berichtsdaten, strukturiert und mit der Originalquelle verknüpft.

Berichtswährung
Geprüfte, quellenverknüpfte Finanzberichte werden geladen, sobald dieser Abschnitt sichtbar wird.

Quellendetails werden mit den Berichtsdaten geladen. Die Werte sind standardisierte Unternehmensangaben zur Research-Unterstützung, keine persönliche Anlageberatung.

Finanzkennzahlen

Jährlich Quartalsweise

Finanzen
Profitabilität
Wachstum
Cashflow
Finanzielle Stabilität
Effizienzkennzahlen

Pennant Group Inc logo

Pennant Group Inc

US$37.08

US$13.30

-64.1% vs price

US$1.3b

-4.64%

52.72%